Table 3.
Patient demographics and clinicopathological characteristics between the QM group and CM group
| Factor | QM (n = 232) |
CM (n = 175) |
Volume | p |
|---|---|---|---|---|
| Gender | χ2 = 1.146 | 0.283 | ||
| Male, n(%) | 149(64.2%) | 104(59.4%) | ||
| Female, n(%) | 83(35.8%) | 71(40.6%) | ||
| Age, years | 67.05 ± 9.49 | 65.96 ± 10.03 | t = 1.359 | 0.233 |
| BMI, kg/m2, median (range) | 24.4(22.3 ~ 26.7) | 24.1(22.3 ~ 26.5) | z = -1.141 | 0.253 |
| Hb, g/L, median (range) | 123.3(116.3 ~ 132.4) | 124.2(115.2 ~ 132.6) | z = -0.427 | 0.667 |
| Alb, g/L, median (range) | 38.7(36.3 ~ 41.5) | 38.5(36.1 ~ 41.2) | z = 0.243 | 0.804 |
| chronic disease | ||||
| Diabetes, n(%) | 27(11.6%) | 25(14.3%) | χ2 = 0.981 | 0.319 |
| Hypertension, n(%) | 41(17.7%) | 38(21.7%) | χ2 = 1.173 | 0.275 |
| pulmonary disease, n(%) | 14(6.0%) | 8(4.6%) | χ2 = 0.389 | 0.536 |
| History of abdominal surgery, n(%) | 34(14.7%) | 21(12.0%) | χ2 = 0.853 | 0.354 |
| Tumor diameter, cm, median (range) | 2.7(1.3 ~ 4.2) | 2.8(1.2 ~ 4.4) | z = -0.726 | 0.463 |
| Tumor Location, n | χ2 = 0.945 | 0.615 | ||
| Upper/Middle/Distal | 77/47/108 | 57/42/76 | ||
| Extent of resection | χ2 = 0.375 | 0.527 | ||
| Total gastrectomy/Distal gastrectomy | 123/109 | 98/76 | ||
| Types of reconstruction | χ2 = 0.375 | 0.527 | ||
| Roux-en-Y/ Billroth-II | 123/109 | 98/76 | ||
| ASA risk score, n(%) | χ2 = 4.027 | 0.131 | ||
| I/II/III | 62/118/52 | 52/97/26 | ||
| Tumor stage, n(%) | χ2 = 3.958 | 0.234 | ||
| I/II/III/IV | 30/74/128/0 | 17/71/87/0 |
BMI Body Mass Index, Hb Hemoglobin, Alb Albumin